跳到主要内容

Medtronic plc (MDT) Stock Forecast 2025 - AI Price Prediction & Analysis


Medtronic plc (MDT) AI Stock Price Forecast & Investment Analysis

Medtronic plc Stock Price Chart and Technical Analysis

Loading Medtronic plc interactive price chart and technical analysis...

Medtronic plc (MDT) - Comprehensive Stock Analysis & Investment Research

Deep dive into Medtronic plc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Medtronic plc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Medtronic plc: Medtronic plc operates in the Industrial Applications and Services sector, positioning it as a large-cap market leader.

Medtronic plc (Stock Symbol: MDT) is a leading company in the Industrial Applications and Services sector , specifically operating within the Electromedical & Electrotherapeutic Apparatus industry.

The organization employs approximately 95000 professionals worldwide .

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Medtronic plc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Medtronic plc: With $34200M in annual revenue and 15.5% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $34200 million generating a 15.5% net profit margin .

Market Capitalization: $119421 million - Classified as a large-cap stock with institutional-grade stability.

Return on Equity (ROE): 9.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Medtronic plc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Medtronic plc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Medtronic plc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Medtronic plc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Medtronic plc: Strong free cash flow generation demonstrates exceptional operational efficiency.

Medtronic plc strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

The company demonstrates robust operational efficiency through strong free cash flow generation of $5678 million annually, complemented by impressive -13.7% year-over-year cash flow growth.

The company maintains a healthy 67.9% gross margin, indicating strong pricing power and operational efficiency.

Medtronic plc (MDT) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Medtronic plc stock analysis.

Loading Medtronic plc comprehensive fundamental analysis and insider trading data...

Deep dive into Medtronic plc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Medtronic plc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Medtronic plc: With a P/E ratio of 25.63, the market highly values future growth prospects.

P/E Ratio 25.63x
P/B Ratio 2.49x
Market Cap $119421M
Dividend Yield 0.03%
EPS $3.63
Book Value/Share $37.03
Revenue/Share $26.44
FCF/Share $3.43
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Medtronic plc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Medtronic plc: An ROE of 9.5% indicates room for improvement in shareholder value creation.

ROE 9.5%
ROA 5.2%
ROIC 6.8%
Gross Margin 67.9%
Net Margin 15.5%
EBT Margin 17.2%
Tax Rate 10.0%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Medtronic plc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Medtronic plc: A current ratio of 2.61 indicates strong liquidity.

Current Ratio 2.61x
Quick Ratio 1.86x
D/E Ratio 0.46x
Financial Leverage 1.75x
Interest Coverage 10.9x
Working Capital $14039M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Medtronic plc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Medtronic plc: Free cash flow of $5678M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $7034M
Free Cash Flow $5678M
Capital Spending $-1356M
OCF Growth YoY -13.7%
FCF Growth YoY -18.9%
FCF/Sales 17.9%
CapEx/Sales 4.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Medtronic plc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Medtronic plc: An asset turnover of 0.34x suggests room for improvement in asset utilization.

Asset Turnover 0.34x
Receivables Turnover 6.0x
Inventory Turnover 2.3x
Fixed Assets Turnover 6.2x
Days Sales Outstanding 61 days
Days Inventory 161 days
Payables Period 68 days
Cash Conversion Cycle 155 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Medtronic plc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Medtronic plc: With annual revenue of $34200M, Medtronic plc operates at significant scale.

Income Statement ($ Millions)
Total Revenue $34200M
Net Income $8136M
R&D Expense $9M
SG&A Expense $32M
Cost of Goods Sold $11531M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 25%
Cash & Short-term Investments 12%
Total Liabilities 43%
Short-term Debt 1%
Accounts Receivable 6%
Inventory 5%
Dividend & Shareholder Information
Dividends Per Share $2.08
Payout Ratio 0.7%
Shares Outstanding 1294M
Growth Metrics (YoY)
EPS Growth 4.1%

Latest Medtronic plc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Medtronic plc (MDT) stock price and investment outlook.

Medtronic plc Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Medtronic plc against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AXGN Unlock Forecast - 30 Days FREE Trial $751M -41.7x 6.7x
BLFS Unlock Forecast - 30 Days FREE Trial $991M -14.7x 2.8x
BSGM Unlock Forecast - 30 Days FREE Trial $126M -1.8x 48.5x
CBLL Unlock Forecast - 30 Days FREE Trial $438M x 2.5x
CNMD Unlock Forecast - 30 Days FREE Trial $1674M 15.2x 1.7x
CUTR Unlock Forecast - 30 Days FREE Trial $9M -0.1x 0.0x
CV Unlock Forecast - 30 Days FREE Trial $0M x x
ECOR Unlock Forecast - 30 Days FREE Trial $37M -7.3x 32.8x
EDAP Unlock Forecast - 30 Days FREE Trial $99M x 2.4x
ELMD Unlock Forecast - 30 Days FREE Trial $218M 28.9x 5.1x
FONR Unlock Forecast - 30 Days FREE Trial $99M 9.5x 0.6x
GTHP Unlock Forecast - 30 Days FREE Trial $22M x x
HSDT Unlock Forecast - 30 Days FREE Trial $66M 0.0x 51.9x
HYPR Unlock Forecast - 30 Days FREE Trial $148M -1.8x 0.9x
INMD Unlock Forecast - 30 Days FREE Trial $1211M x 1.7x
IRIX Unlock Forecast - 30 Days FREE Trial $24M -2.8x 3.9x
IRME Unlock Forecast - 30 Days FREE Trial $1M x x
ITGR Unlock Forecast - 30 Days FREE Trial $3680M 44.5x 2.2x
LIVN Unlock Forecast - 30 Days FREE Trial $3110M -662.0x 2.8x
MASI Unlock Forecast - 30 Days FREE Trial $8006M 128.1x 7.7x
MDT Unlock Forecast - 30 Days FREE Trial $119421M 25.6x 2.5x
MOVE Unlock Forecast - 30 Days FREE Trial $5M -8.6x 0.7x
NDRA Unlock Forecast - 30 Days FREE Trial $2M -0.8x 1.1x
NRXS Unlock Forecast - 30 Days FREE Trial $24M -0.9x 5.6x
NUWE Unlock Forecast - 30 Days FREE Trial $65M -0.1x 18.1x
NXL Unlock Forecast - 30 Days FREE Trial $15M -4.7x 2.4x
NXLIW Unlock Forecast - 30 Days FREE Trial $5M x 1.0x
OM Unlock Forecast - 30 Days FREE Trial $249M -0.4x 1.6x
POCI Unlock Forecast - 30 Days FREE Trial $36M -11.5x 2.8x
QTI Unlock Forecast - 30 Days FREE Trial $7M -0.4x -0.8x
SLNO Unlock Forecast - 30 Days FREE Trial $4417M -18.5x 19.0x
SMLR Unlock Forecast - 30 Days FREE Trial $385M 10.4x 1.0x
STRR Unlock Forecast - 30 Days FREE Trial $7M -1.6x 0.1x
STRRP Unlock Forecast - 30 Days FREE Trial $31M -5.5x 0.5x
STXS Unlock Forecast - 30 Days FREE Trial $1182M -8.4x 811.5x
TIVC Unlock Forecast - 30 Days FREE Trial $3M 0.0x 0.8x
TMDX Unlock Forecast - 30 Days FREE Trial $4337M 60.5x 13.6x
VANI Unlock Forecast - 30 Days FREE Trial $92M -2.7x 7.9x
VASO Unlock Forecast - 30 Days FREE Trial $21M 20.1x 0.8x
ZYXI Unlock Forecast - 30 Days FREE Trial $46M 41.4x 36.5x

Frequently Asked Questions - Medtronic plc Stock Forecast

How accurate are Medtronic plc stock predictions?

Our AI model demonstrates 44% historical accuracy for MDT predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Medtronic plc stock price forecasts?

Our analysis considers Medtronic plc's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Medtronic plc a good investment in 2025?

Based on our AI analysis, Medtronic plc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Medtronic plc forecasts updated?

Medtronic plc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Medtronic plc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Medtronic plc stock.

My Portfolio

Investment Dashboard

Loading your portfolio...